Objective: The goal of this study was to determine if the hemodynamic effects of the combined administration of an angiotensin converting enzyme (ACE) inhibitor and angiotensin II type 1 (AT ) receptor antagonist are greater than those produced by either of these 1 agents administered individually during heart failure. Methods: Ten farm pigs were chronically instrumented with aortic, left atrial and right atrial catheters, a left ventricular (LV) pressure gauge, LV dimension crystals, coronary occluders, an ascending aortic flow probe and pacing leads. Heart failure was induced by serial myocardial infarctions followed by repeated rapid ventricular pacing. Results: Heart failure was manifested by significant ( p,0.01) decreases in LV dP/ dt (23865%, from 29436107 mmHg / s) and cardiac output (22764%, from 4.160.2 l / min) and increases in left atrial pressure (11861 mmHg, from 461 mmHg) and total peripheral resistance (TPR)(14068%, from 2362 mmHg / l / min). The effects of an ACE inhibitor (enalaprilat) and an AT receptor antagonist (L-158,809), 1 administered in maximally effective doses, either individually or concomitantly, were examined on different days in conscious pigs with heart failure. There were no differences in any of the baseline hemodynamic measurements among the groups studied. Thirty minutes after administration, enalaprilat (4 mg / kg i.v.) increased ( p,0.05) cardiac output by 862% and reduced ( p,0.05) mean arterial pressure and TPR by 561 and 1261%, respectively, while the changes in LV dP/ dt (062%), LV fractional shortening (1463%) and heart rate (1161%) were not statistically significant. Similarly, L-158,809 (4 mg / kg, i.v.) increased cardiac output by 962% and reduced mean arterial pressure and TPR by 461 and 1163%, respectively, while the changes in LV dP/ dt (1363%), LV fractional shortening (1361%) and heart rate (061%) were not significant. However, enalaprilat (1 mg / kg, i.v.) and L-158,809 (1 mg / kg, i.v.), administered concomitantly, reduced TPR by 2163%, an effect greater ( p,0.05) than when either of these agents was administered individually at a dose of 4 mg / kg, i.v. The changes in mean arterial pressure (2962%), cardiac output (11564%) and LV fractional shortening (11163%) also tended to be greater with concomitant administration. In addition, in a sequential dosing protocol, when L-158,809 (1 mg / kg, i.v.) was administered 30 min after enalaprilat (1 mg / kg, i.v.), TPR was reduced by 2064% compared to only a 663% reduction ( p,0.05) when the enalaprilat was followed 30 min later by a second dose of enalaprilat (1 mg / kg, i.v.). The changes in mean arterial pressure and cardiac output for the combined treatment group also tended to be greater than those for the group given two sequential doses of enalaprilat. Conclusion: In conscious pigs with heart failure, the combined vasodilatory effects of an ACE inhibitor and AT 1 receptor antagonist are greater than those produced when only one of these agents is administered, suggesting that independent mechanisms of ACE inhibition and AT receptor antagonism could be partly responsible for the improved vascular dynamics during heart 1 failure.
Introduction
congestive heart failure is a progressive inability of the left ventricle (LV) to provide sufficient blood for organ One of the important hemodynamic abnormalities in perfusion. As a consequence of LV dysfunction, neurohormonal pathways are activated in an attempt to maintain adequate perfusion pressure by causing vasoconstriction atria, to measure pressures, and in the right atrium, to [1] . It is generally accepted that angiotensin converting administer drugs. A solid-state miniature pressure gauge enzyme (ACE) inhibitors effectively prevent an increase in (Konigsberg Instruments, Pasadena, CA, USA) was imperipheral vascular resistance by inhibiting the formation planted in the LV chamber, to obtain LV pressure and the of angiotensin II, a potent vasoconstrictive hormone.
rate of change of LV pressure (LV dP/ dt). A pacing lead However, recent studies suggest that angiotensin II can be (model 5069, Medtronic, Minneapolis, MN, USA) was generated via ACE-independent pathways, such as by the attached to the right ventricular free wall, and stainless chymotrypsin-sensitive angiotensin II-generating enzyme steel pacing leads were attached to the left atrial appen-[2-6]. On the other hand, in addition to attenuating the dage. The left circumflex coronary artery was isolated, and biosynthesis of angiotensin II, ACE inhibitors potentiate two hydraulic occluders made of Tygon tubing were the activity of the kallikrein-kinin systems, leading to implanted proximally and distally to the first obtuse accumulation of endogenous bradykinin [7] [8] [9] . Increased marginal branch. In nine pigs, a flow probe with a diameter levels of vascular bradykinin are thought to contribute of either 20 or 24 mm (Transonic Systems, Ithaca, NY, vasodilatory support during heart failure [10] [11] [12] [13] [14] , through USA) was placed around the ascending aorta to measure the mediation of nitric oxide, prostacyclin and endocardiac output, and one pair of piezoelectric ultrasonic thelium-derived hyperpolarizing factor [15, 16] . dimension crystals were implanted on opposing anterior Accordingly, we hypothesized that the hemodynamic and posterior endocardial regions of the left ventricle, to effects, particularly the vasodilatory action, of the commeasure the short-axis internal diameter. Proper alignment bined administration of an angiotensin II receptor antagoof the endocardial crystals was achieved during surgical nist and an ACE inhibitor would be greater than the effects implantation by positioning the crystals to obtain a signal produced by either one of these agents administered with the greatest amplitude and shortest transit time. The individually during congestive heart failure. To test this wires and catheters were externalized between the hypothesis and to determine if the combined therapy has scapulae, the incision was closed in layers, and air was any detrimental hemodynamic effects in congestive heart evacuated from the chest cavity. All of the surgical failure, the cardiac and systemic dynamic effects of the procedures and instrumentation implanted in this study ACE inhibitor, enalaprilat, and a selective angiotensin II were similar to those described in our previous studies type 1 (AT ) receptor antagonist, L-158,809 [17, 18] , were [19] [20] [21] . The pigs used in this study were maintained in 1 examined in chronically instrumented, conscious pigs with accordance with the Guide for the Care and Use of stable advanced congestive heart failure. Heart failure was Laboratory Animals of the Institute of Laboratory Animal induced by serial myocardial infarctions followed by Resources, the National Council [Department of Health repeated rapid ventricular pacing [19] . (cardiac output) were measured using an amplifier filter. USA) were implanted in the descending aorta and in both Stroke volume was calculated as the quotient of cardiac output and heart rate. LV dimension was measured with an concomitantly (n58); (7) 1 mg / kg enalaprilat followed 30 ultrasonic transit-time dimension gauge (Model 203, Triton min later by 1 mg / kg L-158,809 (n57) and (8) 1 mg / kg Technology). Total peripheral resistance was calculated as enalaprilat followed 30 min later by a second dose of 1 the quotient of mean arterial pressure and cardiac output. mg / kg enalaprilat (n55). Hemodynamic measurements LV short-axis end-diastolic dimension (EDD) was meawere continuously recorded before and for 90 min after sured at the beginning of the upstroke of the LV dP/ dt intravenously injecting each of the agents or the vehicle signal. LV end-systolic dimension (ESD) was measured at during a 2-min period. Treatment dosages and timing in the time of minimum dP/ dt. The percentage shortening of these eight treatment regimens were determined in pilot the LV internal diameter was calculated as (EDD2ESD) / studies. Enalaprilat was dissolved in 0.9% saline, and EDD?100. The LV velocity of circumferential fiber short-L-158,809 was dissolved in saturated NaHCO and 0.9% 3 ening (Vcf) was calculated from the dimension measuresaline (10:90, v / v), at a concentration of 2 mg / ml. ments using the following formula: (EDD2ESD) / EDD/ 21 ejection time (s ). Ejection time was measured as the 2.5. Data analysis interval between the maximum and minimum LV dP/ dt. A cardiotachometer triggered by the LV pressure signal Data before and after development of heart failure were provided instantaneous and continuous records of heart compared using Student's t-test for paired data. Comrate.
parisons between the groups were performed using Student's grouped t-test when only two groups were com-2.3. Congestive heart failure model pared and analysis of variance when more than two groups were compared. Data between the baseline and multiple After the pigs had fully recovered from the surgery, i.e., responses to treatment over time were performed using ten-fourteen days after surgery, heart failure was induced Student's t-test for paired data with a Bonferroni correcby two coronary artery occlusions and subsequent intermittion. All values were expressed as the mean6S.E. Statistitent tachycardiac pacing [19] . Briefly, after post-surgical cal significance was accepted at the p,0.05 level. hemodynamic control monitoring, the left circumflex coronary artery was occluded distal to the origin of the first marginal branch, by inflating the distally implanted hy-3. Results draulic occluder. Approximately 48 h after the first occlusion, the proximal circumflex coronary artery occluder was 3.1. Baseline hemodynamics before and after inflated. The right ventricle was then paced at a rate of development of heart failure 210-220 beats / min using a programmable external cardiac pacemaker (model EV4543, Pace Medical, Waltham, MA, Table 1 summarizes the baseline LV function and USA) beginning one to four days (2.660.5 days), dependsystemic vascular dynamics before and after heart failure ing on the condition of the animal, after the second in conscious pigs. Heart failure resulting from two cycles myocardial infarction. This pacing was continued for one of tachycardiac pacing in the presence of myocardial injury week and then terminated for three days. This procedure was manifested by significant ( p,0.01) decreases in LV was repeated for another one-two cycles, until hemodP/ dt, LV fractional shortening, Vcf, stroke volume and dynamic parameters were stable. In addition to the hemocardiac output, by 3865, 5266, 4965, 2965 and 2764% dynamic changes, heart failure was also characterized by from their respective baseline values, i.e., before heart anorexia, peripheral and pulmonary edema, and reduced failure. Total peripheral resistance increased significantly physical activity.
( p,0.01), by 4068% from baseline. LV end-diastolic (13066%) and LV end-systolic diameters (15169%), 2.4. Experimental protocols and mean left atrial pressure (11861 mmHg) were significantly ( p,0.01) increased, while mean arterial Baseline hemodynamic recordings were made before pressure was unchanged and heart rate was slightly ininducing heart failure. Experiments were performed after creased. the pigs had achieved stable heart failure, i.e., during the second and third pacing cycles, while they were conscious 3.2. Effects of ACE inhibitor and AT receptor 1 and quietly restrained in a sling. Experimental protocols antagonist administered individually or concomitantly consisted of eight treatment regimens with the ACE during heart failure inhibitor, enalaprilat, and / or the AT receptor antagonist, resistance and heart rate in conscious pigs with heart The effects of enalaprilat at a dose of 4 mg / kg i.v., of failure. Peak effects occurred approximately 15 min fol-L-158,809 at a dose of 4 mg / kg i.v., and of both agents lowing drug administration. Enalaprilat and L-158,809, at administered concomitantly, each at a dose of 1 mg / kg doses of 1 or 4 mg / kg, each induced a small but significant i.v., on cardiac and systemic hemodynamics in conscious decrease ( p,0.05) in mean arterial pressure, an approxipigs with heart failure are shown in Table 2 . There were no mately 15% reduction ( p,0.05) in total peripheral resistdifferences in any of the measurements among the groups ance and a moderate increase ( p,0.05) in cardiac output, before treatment. When administered concomitantly, without inducing a significant change in LV dP/ dt, LV enalaprilat and L-158,809, each at a dose of 1 mg / kg i.v., fractional shortening or heart rate. However, enalaprilat (1 decreased mean arterial pressure and increased cardiac mg / kg, i.v.) and L-158,809 (1 mg / kg, i.v.) administered output more than when either enalaprilat or L-158,809 was concomitantly or sequentially, i.e., a 1 mg / kg i.v. dose of administered individually at a dose of 4 mg / kg i.v. Also, enalaprilat followed 30 min later by a 1 mg / kg i.v. dose of the increase in LV fractional shortening and the decrease in L-158,809, elicited greater hemodynamic effects.
left atrial pressure also tended to be greater following the combined treatment compared to the individual treatments, compared to values before heart failure. In contrast, there although these differences were not statistically significant.
was no difference in total peripheral resistance between the However, total peripheral resistance was reduced signifigroup with heart failure that was treated with combined cantly ( p,0.05) more 30 min after concomitant adminis-ACE inhibitor and AT receptor antagonist vs. the control 1 tration of the agents compared to when only enalaprilat or group (i.e., before heart failure). That is, in this heart L-158,809 was administered. The 90 min time courses of failure model, combined ACE inhibitor and AT receptor 1 the changes in mean arterial pressure, cardiac output, total antagonist treatment normalized total peripheral resistance peripheral resistance and heart rate after administering the to pre-heart failure values. agents individually or concomitantly are shown in Fig. 2 . Fig. 3 shows a comparison of the absolute values of LV 3.3. Effects of ACE inhibitor followed by AT receptor 1 dP/ dt, mean arterial pressure, mean left atrial pressure and antagonist during heart failure total peripheral resistance before heart failure and during heart failure both before and 30 min after individual or
In a sequential dosing protocol, an initial 1 mg / kg i.v. combined treatment with enalaprilat and L-158,809. Aldose of enalaprilat was followed 30 min later by a though the individual administrations of enalaprilat or 1 mg / kg i.v. dose of either L-158,809 or a second dose of L-158,809 reduced the total peripheral resistance, the enalaprilat. doses of enalaprilat. Fig. 4 shows the time course of the failure. To test this hypothesis, we used chronically percent changes in mean arterial pressure, cardiac output, instrumented, conscious pigs in which congestive heart total peripheral resistance and heart rate during both failure had been induced by intermittent, rapid ventricular protocols. In the presence of enalaprilat, there was a pacing in the presence of previous myocardial infarction. significantly greater ( p,0.05) decrease in total peripheral This unique model was recently developed in our laboraresistance 15 and 30 min after administering L-158,809 tory [19] and has the following characteristics: (1) The compared to that found after administering a second dose etiology of heart failure is similar to that in humans, where of enalaprilat. Administering L-158,809 after enalaprilat it is commonly initiated from multiple myocardial infarcts also increased cardiac output more than did a second dose caused by coronary artery disease, (2) once heart failure of enalaprilat, but the difference was only significant ( p, (i.e., severe LV contractile dysfunction) has developed, it is 0.05) 45 min after administering the initial dose of relatively stable, so multiple protocols performed on enalaprilat. The decrease in mean arterial pressure was different days can be compared, (3) unlike the canine rapid slightly ( p.0.05) enhanced by the dose of L-158,809
pacing-induced heart failure model [22] , LV dysfunction is compared to the second dose of enalaprilat, while heart associated with elevated peripheral vascular resistance and rate was unchanged in either protocol.
(4) the data are not influenced by recent surgical trauma and anesthesia, which can significantly affect neurohumoral systems [23] [24] [25] [26] . The latter is particularly important in 4. Discussion the present study, since the renin-angiotensin system interacts closely with the baroreflex and autonomic nerWe hypothesized that the combined administration of an vous systems [27] [28] [29] . ACE inhibitor and angiotensin II receptor antagonist would
We selected enalaprilat as the ACE inhibitor and Lproduce greater hemodynamic effects than either of these 158,809 as a potent and selective AT receptor antagonist 1 agents administered individually during congestive heart [17, 18] . The results show that the ACE inhibitor enalap- hemodynamic effects of a 4 mg/kg dose of enalaprilat or mg / kg) was administered 30 min after administering the L-158,809 were not significantly different from those ACE inhibitor (1 mg / kg) in the sequential dosing protocol, observed with a 1 mg / kg dose of either of these two it clearly enhanced the vasodilatory response. In contrast, agents, suggesting that the maximal hemodynamic rewhen a second dose of the ACE inhibitor (1 mg / kg) was sponses were elicited. Therefore, it is unlikely that inadministered instead of the AT receptor antagonist, to 1 creased doses of either agent in any of the protocols would exclude the possibility that the additive effect was due to have resulted in any increased or detrimental hemodymultiple dosing, the second dose of ACE inhibitor did not namic responses.
induce any additional change in vascular resistance, which The results from two different experimental protocols, in also supports the results from the first set of experiments. which both the ACE inhibitor and the AT receptor These data are consistent with preliminary studies by 1 antagonist were administered, support our hypothesis. Spinale et al. [30, 31] in which chronic treatment with the First, the elevated vascular resistance in heart failure was ACE inhibitor, benazepril, combined with the AT re- ment enhances the individual vasoactive effects of the vasodilator treatment strategies, the combined administra-ACE inhibitor and the AT receptor antagonist is not quite tion of an ACE inhibitor and an AT receptor antagonist 1 1 understood, one can speculate based on existing knowlmight have greater long-term efficacy than that provided edge. It is known that a significant amount of angiotensin by either agent alone, since both ACE inhibitors and II can be formed despite ACE inhibition [4, 6] . Alternative angiotensin II receptor antagonists have tissue growth-ACE-independent pathways, such as the chymotrypsininhibiting properties via different pathways, i.e., the nitric sensitive angiotensin II-generating enzyme, have been oxide-and protein kinase C-mediated pathways, respecreported to be largely involved in angiotensin II formation tively [10] . In addition, angiotensin II interacts uniquely [2-6]. Therefore, we would expect that using an AT with the enhanced central gain of the cardiac sympathetic 1 receptor antagonist to block the angiotensin II pathway at a afferent reflex [34] . more distal level would result in additional vasodilation, In summary, in conscious pigs with congestive heart even in the presence of ACE inhibition. Also, ACE failure induced by myocardial infarction and repeated interacts with the kininase-II of the kallikrein-kinin systachycardiac stress, the acute, combined administration of tems in such a way that inhibition of ACE potentiates the an ACE inhibitor and an AT receptor antagonist had a 1 activity of these systems, leading to an accumulation of greater vasodilatory effect than did either of these agents endogenous bradykinin [7] [8] [9] . It is believed that bradywhen administered individually, even when administered kinin causes vascular endothelium-dependent relaxation at a dose that was twice as great as that of the combined that is mediated by release of nitric oxide, prostacyclin and treatment. Neither the combined nor the individual treatendothelium-derived hyperpolarizing factor [15, 16] . Bements significantly affected myocardial contractility. cause of these unique dual-actions of ACE, it is conceivWhether or not the combined treatment has long-term able that ACE inhibitors would augment the vasodilatory beneficial effects during the development of congestive effects of angiotensin II receptor antagonists. Our results heart failure requires further study. support the existence of these independent pathways of the renin-angiotensin systems.
In the present study, we also observed that LV per
